NCT06407583 (ProMIO2) is a NA clinical trial of ProMIO2.0 program in Sarcopenia, sponsored by Amsterdam University of Applied Sciences.

Who is sponsoring NCT06407583?

NCT06407583 is sponsored by Amsterdam University of Applied Sciences.

What drugs are being tested in NCT06407583?

Interventions in NCT06407583: ProMIO2.0 program.

What condition does NCT06407583 study?

NCT06407583 studies Sarcopenia, Diabetes, Overweight, Ethnic Minorities, Musculoskeletal Diseases.

Is NCT06407583 still recruiting?

NCT06407583 is currently completed. Last updated 9 May 2024.

Last reviewed 2024-05-09 · How we verify

NCT06407583: ProMIO2

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

ProMIO2.0; A Powerful Lifestyle Intervention for Older Adults From Ethnic Minorities

Completed NA Last updated 9 May 2024

What this trial tests

NA trial testing ProMIO2.0 program in Sarcopenia in 76 participants. Completed in 8 June 2023.

Timeline

24 May 2022

Primary endpoint
8 June 2023

8 June 2023

Quick facts

Lead sponsor	Amsterdam University of Applied Sciences
Phase	NA
Status	Completed
Study type	INTERVENTIONAL
Allocation	randomized
Design	parallel
Masking	single
Primary purpose	prevention
Enrollment	76
Start date	24 May 2022
Primary completion	8 June 2023
Estimated completion	8 June 2023
Sites	1 location across Netherlands

Drugs / interventions tested

ProMIO2.0 program

Conditions studied

Sarcopenia — all drugs for Sarcopenia →
Diabetes — all drugs for Diabetes →
Overweight — all drugs for Overweight →
Ethnic Minorities — all drugs for Ethnic Minorities →

Sponsor

Amsterdam University of Applied Sciences

Who can join

55 and older, any sex, with Sarcopenia or Diabetes. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

Older adults from ethnic minorities show on average a worse disease risk profile compared to the majority populations. An important risk factor to develop chronic diseases is the loss of muscle mass and functioning, also known as sarcopenia. Several randomized controlled trials (RCTs) showed that the combination of adequate protein intake and physical exercise is most effective to prevent the loss of muscle mass, strength and functioning in older adults. However, until shortly, no intervention that included protein and exercise was available that accounted for the special socio-cultural needs of ethnic minority populations. Therefore the Amsterdam University of Applied Sciences (AUAS) and ProMIO project group developed a cultural sensitive lifestyle intervention with protein and exercise carried out by dieticians and physical therapists to provide a tailored treatment for older adults from ethnic minorities. This project aims to evaluate the effectiveness of this new intervention on protein intake, physical activity behavior, muscle mass, muscle strength, function and quality of life. The cost-effectiveness of this new intervention will also be evaluated.

Publications & conference data

1 peer-reviewed publication reference this trial (live from Europe PMC):

Culture-sensitive lifestyle intervention tailored to non-Western migrant older adults improves physical performance: A randomized controlled trial.
Biersteker EJM, van den Helder J, van der Spek N, Holwerda M, et al · · 2025 · cited 1× · PMID 40409139 · DOI 10.1016/j.jnha.2025.100584

Verify or expand the search:

Other recruiting trials for Sarcopenia

Currently open trials in the same condition.

NCT07500376 — Multimodal Nutritional and Sarcopenia Assessment for Risk Stratification in Lung Cancer Surgery · recruiting
NCT07456956 — HIIT vs MCIT for Stroke-Related Sarcopenia in Ischemic Stroke · NA · recruiting
NCT07398495 — Multimodal Training Effects in Middle-Aged and Older Adults With Diabetic Sarcopenia · NA · recruiting
NCT07494916 — Effects of Functional Task Training on Muscle Health and Function in Older Adults With Sarcopenia · NA · active not recruiting
NCT07426159 — AI-Guided Sarcopenia Risk Assessment and Detection · NA · active not recruiting

Other Amsterdam University of Applied Sciences trials

Trials by the same sponsor.

NCT07429136 — Plant-based Protein-rich Weight Loss Intervention in 55+ Adults With Obesity · NA · recruiting
NCT06172725 — Improvements by a Protein-rich Plant-based Diet and Resistance Exercise Program for Active Ageing · NA · completed
NCT06192732 — Environmentally Sustainable Nutrition for Older Adults (55+) With Obesity · NA · unknown

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT06407583 (US National Library of Medicine, public domain)
Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Amsterdam University of Applied Sciences
Last refreshed: 9 May 2024

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT06407583.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing